next steps for sanovo trial for egfrm /met nsclc
Published 2 years ago • 34 plays • Length 0:27Download video MP4
Download video MP3
Similar videos
-
4:39
background of sanovo trial for patients with advanced nsclc
-
0:56
next steps for the convert trial in ls-sclc
-
3:30
comparing progression-free survival in the astris and sanovo trials
-
4:13
next steps in nsclc: checkpoint inhibitors plus cellular therapy
-
3:44
immunotherapy as combination and neoadjuvant therapies in nsclc
-
5:59
targeted therapy in consolidation setting for lung cancer
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial
-
1:33
neoadjuvant egfr tki trials in nsclc
-
2:01
upcoming nsclc trials in 2022: checkmate 816 & keynote-091
-
2:22
moving immunotherapy to earlier lines in nsclc
-
8:44
flaura final analysis: osimertinib for first-line egfrm nsclc
-
1:47
clinical trial designs and ongoing trials in immunotherapy for lung cancer
-
1:07
pacific trial updates: durvalumab after chemotherapy in nsclc
-
3:59
pacific trial of durvalumab for stage iii nsclc
-
1:13
a new standard of care for advanced lung cancer: what’s next for pembrolizumab?
-
2:06
adaura trial: osimertinib for early stage egfr nsclc - 2022 program: targeted therapies forum
-
16:51
post esmo update on impower clinical trial in early stage nsclc
-
4:17
harmonic clinical trial for patients with nsclc - non-small cell lung cancer is enrolling patients
-
8:14
approaching non-driver stage iv nsclc